Atlas Trials

MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer

Clinical trial NCT02041481 · COMPLETED

Trial details

NCT number
NCT02041481
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon CancerStage IVA Rectal CancerStage IVB Colon CancerStage IVB Rectal Cancer
Start date
2014-06-01
Primary completion
2018-01-19
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.